Browse > Article
http://dx.doi.org/10.23093/FSI.2017.50.1.11

What is Epigenomics and how it will be applied to the food industry?  

Yoo, Jin Young (Department of Food Science and Biotechnology, CHA University)
Han, Ga Eun (Department of Food Science and Biotechnology, CHA University)
Lee, Jong Hun (Department of Food Science and Biotechnology, CHA University)
Publication Information
Food Science and Industry / v.50, no.1, 2017 , pp. 11-15 More about this Journal
Abstract
Epigenomics is a study that analyzes and quantifies various epigenetic alterations that affect gene expressions in cells from the viewpoint of collective characteristics on biological molecular pools. DNA methylation and histone modification in cells can induce the epigenetic alterations. Especially, epigenetic alterations influenced by external factors as ingested foods and other environmental factors have been examined in the whole genome regions, which provide accumulated data of altered regions or patterns of global genome, Statistical analyses of these regions or patterns enables us to correlate epigenomic changes with human diseases in the whole genome region. Finding meaningful regulators is a major concern of epigenomic research in recent years, and these results will give the food industry an important clue to future food
Keywords
epigenomics; epigenetics; DNA methylation; histone modification;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science 286: 481-6 (1999)   DOI
2 Li Y, Kong D, Wang Z, Sarkar FH. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm. Res 27: 1027-41 (2010)   DOI
3 Li Y, Tollefsbol TO, Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr. Med. Chem. 11: 2141-51 (2010)
4 Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 11: 228-34 (2009)   DOI
5 Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. Nat. Rev. Drug Discov. 5: 37-50 (2006)   DOI
6 Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16: 6-21 (2002)   DOI
7 Rodenhiser D, Mann M. Epigenetics and human disease: translating basic biology into clinical applications. Canadian Med. Assoc. J. 174: 341-8 (2006)   DOI
8 Dolinoy DC, Weidman JR, Jirtle RL. Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod. Toxicol. 23: 297-307 (2007)   DOI
9 Jones PA, Baylin SB. The foundamental role of epigenetic events in cancer. Nat. Rev. Genet 3: 415-28 (2002)   DOI
10 Zaidi SK, Young DW, Montecino M, Lian JB, Stein JL, van Wijnen AJ, Stein GS. Architectural epigenetics: mitotic retention of mammalian transcriptional regulatory information. Mol. Cell. Biol. 30: 4758-66 (2010)   DOI
11 Prendergast GC, Ziff EB, Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251: 186-9 (1991)   DOI
12 Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell Biol. 18: 6538-47 (1998)   DOI
13 Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, Bird A. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69: 905-14 (1992)   DOI
14 Feng Q, Zhang Y. The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev. 15: 827-32 (2001)
15 Lund AH, van Lohuizen M. Epigenetics and cancer. Genes Dev. 18: 2315-35 (2004)   DOI
16 Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum. Mol. Genet. 16 Spec No 1: R50-9 (2007)   DOI
17 Berlowilz L, Pallotta D. Acetylation of nuclear protein in the heterochromatin and euchromatin of mealy bugs. Exp. Cell Res. 71: 45-8 (1972)   DOI
18 Tremethick DJ. Higher-order structures of chromatin: the elusive 30 nm fiber. Cell 128: 651-4 (2007)   DOI
19 Lee JH, Khor TO, Shu L, Su ZY, Fuentes F, Kong AN. Dietary phytochemicals and cancer prevention: Nrfl signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression. Pharmacol. Ther. 137: 153-71 (2013)   DOI
20 Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 129: 823-37 (2007)   DOI
21 Yang AY, Lee JH, Shu L, Zhang C, Su ZY, Lu Y, Huang MT, Ramirez C, Pung D, Huang Y, Verzi M, Hart RP, Kong AN. Genome-wide analysis of DNA methylation in UVB- and DMBA/TPA-induced mouse skin cancer models. Life Sci. 113: 45-54 (2014)   DOI
22 Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10: 32-42 (2009)   DOI
23 Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63: 7563-70 (2003)
24 Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp. Biol. Med. 232: 227-34 (2007)
25 Shu L, Khor TO, Lee JH, Boyanapalli SS, Huang Y, Wu TY, Saw CL, Cheung KL, Kong AN. Epigenetic CpG Demethylation of the Promoter and Reactivation of the Expression of Neurog1 by Curcumin in Prostate LNCaP Cells. Amer. Assoc. Pharmaceut. Scientists J. 13: 606-14 (2011)
26 Pandey M, Shukla S, Gupta S. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int. J. Cancer 126: 2520-33 (2010)